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Normalization of reverse transcription (RT)-qPCR data 
using stably expressed reference genes is essential for accu-
rately profiling gene and microRNA (miRNA) expression 
[1-4]. Genes that are constitutively expressed and are associ-
ated with housekeeping or structural functions are commonly 
used as reference genes, as they tend to be expressed across 
many cell and tissue types and show minimal variation among 
samples or experimental conditions [4-7]. However, evidence 
suggests that the expression of commonly used reference 
genes such as glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH) and beta-actin varies between cell and tissue 
types [8,9]. Identifying and characterizing stably expressed 
reference genes through a series of preliminary experiments 
is recommended, to accurately determine gene and miRNA 
expression levels and to avoid incorrect conclusions being 
drawn [3,6,10,11].
Retinopathy of prematurity (ROP) is a potentially 
blinding condition that affects premature infants who 
undergo supplemental inspired oxygen therapy. Oxygen-
induced retinopathy (OIR) is a robust animal model of ROP 
that mimics the pathology seen in human disease [12,13]. The 
rat model of OIR described in this study utilizes exposure of 
neonatal rats to cyclic hyperoxia and relative hypoxia [14-17]. 
As changes in retinal gene expression in response to exposure 
of neonates to hyperoxia and relative hypoxia are involved 
in inducing OIR [18-21], identifying references genes that 
are stable with variations in oxygen levels is vital. Previous 
studies from our laboratory identified two RNA reference 
genes encoding acidic ribosomal phosphoprotein and hypo-
xanthine guanine phosphoribosyl transferase as being stably 
expressed in response to cyclic hyperoxia and during early 
retinal development in several different rat strains [5], making 
these reference genes suitable for normalizing gene expres-
sion data.
MicroRNAs expressed in the eye are associated with 
physiologic and pathological processes and display tissue 
specificity and spatiotemporal expression [22,23]. In mouse 
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Purpose: Oxygen-induced retinopathy (OIR) is a robust animal model of human retinopathy of prematurity that readily 
allows changes in retinal gene and microRNA (miRNA) expression in response to fluctuations in oxygen levels to be 
studied. We sought to identify small non-coding RNA (ncRNA) genes that showed stable expression upon exposure to 
varying levels of oxygen, with different developmental stages and in different rat strains, to act as reference genes for 
normalizing miRNA expression in a rat model of OIR.
Methods: Expression of five small ncRNAs (U6 snRNA, miR-16, U87, 4.5S RNA (H) “Variant 1”, and 5S ribosomal 
RNA [rRNA]) were tested on a standard RNA pool and representative retinal samples from P5, P6, P9, and P14 from room 
air– and cyclic hyperoxia–exposed rats using reverse transcription (RT)-qPCR, to assess the effect of developmental 
stage and exposure to fluctuations in oxygen levels, respectively. Two strains of inbred albino rats, Fischer 344 (F344, 
resistant to OIR) and Sprague-Dawley rats (SD, susceptible to OIR), were used to assess the effect of rat strain on the 
stability of the small ncRNAs.
Results: In this rat model of OIR, 5S rRNA expression was variable with strain, fluctuations in oxygen levels, and de-
velopmental stage. U6 snRNA was stably expressed with changes in oxygen levels, and minimal variation was observed 
with strain and developmental stage. MiR-16 showed less stable expression with changes in oxygen levels and between 
strains compared to U6 snRNA. Some variation in expression in response to developmental stage was also observed. The 
PCR amplification efficiencies of the U6 snRNA and miR-16 TaqMan assays were 56% and 78%, respectively. U87 and 
4.5S RNA (H) “Variant 1” expression varied with strain, exposure to cyclic hyperoxia, and in particular developmental 
stage, and was at low levels in the neonatal rat retina.
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models of OIR, miRNAs regulate retinal angiogenesis by 
post-transcriptional modification of genes involved in the 
angiogenic response to hypoxia [24,25].
5S ribosomal RNA (rRNA), a commonly used reference 
transcript for miRNA RT-qPCR, has been used to normalize 
miRNA expression in mouse models of OIR [24-26]. Unlike 
the reference genes used in normalizing gene expression 
that are typically protein-coding genes, the reference genes 
used for normalizing miRNA expression should, in general, 
be small non-coding RNAs (ncRNAs) such as small nuclear 
and small nucleolar RNAs, given that the total RNA isolation 
process biases toward the recovery of large RNAs over small 
ncRNAs [4,27]. However, the choice of the correct normaliza-
tion RNA appears to depend on the context in which miRNA 
expression is being investigated [10,28]. Whether 5S rRNA is 
the most appropriate small ncRNA for normalizing miRNA 
expression in rodent models of OIR is currently unknown, as 
stable expression of 5S rRNA with changes in oxygen levels 
has not previously been established. We sought to identify 
small ncRNAs that showed stable expression upon exposure 
to varying levels of oxygen, in different rat strains and at 
different developmental stages to act as reference genes for 
normalizing miRNA expression in a rat model of OIR.
METHODS
Experimental animals: Albino inbred Fischer 344 (F344; 
resistant to OIR) and Sprague-Dawley (SD; susceptible to 
OIR) rats and pigmented inbred Dark Agouti (DA; suscep-
tible to OIR) rats were obtained from the institutional animal 
facility. Rats were allowed unlimited access to rat chow 
and water and were exposed to a 12 h:12 h light-dark cycle. 
Temperature was maintained at 24 °C in a humidified atmo-
sphere. Animals were euthanized with an inhaled overdose 
of isoflurane anesthetic. All experiments were approved 
by the institutional Animal Welfare Committee and met 
the standards described in the Association for Research in 
Vision and Ophthalmology Statement for the Use of Animals 
in Ophthalmic and Vision Research and those set out by the 
Australian Code of Practice for the Care and Use of Animals 
for Scientific Purposes.
Exposure of neonatal rats to cyclic hyperoxia: The oxygen 
exposure protocol used in this study was a modification 
of those previously used in other studies of OIR in the rat 
[15-17,29,30]. Within 12 h of birth, female rats and their litters 
were placed in a custom-built humidified chamber designed 
to deliver oxygen to neonatal rat litters under controlled 
conditions. Rats were exposed to alternating 24 h cycles of 
hyperoxia (80% oxygen in air) and room air (normoxia; 21% 
oxygen in air) for a maximum of 14 days after birth. Age- and 
strain-matched room air–exposed rats were used as controls.
Preparation of total RNA from rat retinas: Total RNA was 
prepared from the retinas of neonatal rats as described previ-
ously [31], using TRIzol (Invitrogen, Carlsbad, CA) according 
to the manufacturer’s method. Total RNA was also prepared 
from the rat liver, brain and lung, and mouse lens and liver 
using the same method. Mouse liver and lens tissue were 
kindly provided by Dr. Shiwani Sharma (Flinders University, 
Adelaide, South Australia). Quantification of total RNA was 
performed using the NanoDrop 8000 (Thermo Scientific, 
Wilmington, DE). An absorbance ratio of the RNA at 260 
and 280 nm was used as a guide to determine RNA purity. 
Total RNA with a ratio of 1.8 or more was considered accept-
able. Agarose gel electrophoresis was used to assess RNA 
integrity and residual DNA contamination. Total RNA with 
a 28S:18S ratio of approximately 2:1 and showing minimal 
DNA contamination was considered acceptable for use.
Preparation of cDNA for qPCR: cDNA was prepared from 
total RNA for each individual sample from room air- and 
cyclic hyperoxia-exposed F344 and SD rats at P5, P6, P9, 
and P14 using a method described previously [31]. Briefly, 
one microgram of total RNA was DNase-treated with Turbo 
DNAfree (Ambion, Austin, TX) according to the manufac-
turer’s instructions and reverse-transcribed in 20 μl reac-
tions using a first-strand cDNA synthesis kit (SuperScript 
III First-Strand Synthesis System, Invitrogen) and random 
hexamer primers. An RT-free control sample was prepared 
in parallel with each cDNA sample, in which diethylpyro-
carbonate (DEPC)-treated water was used in place of reverse 
transcriptase. Relative quantification of gene expression was 
performed on cDNA from each individual sample at a 1:5 
dilution. A single representative room air– or cyclic hyper-
oxia–exposed rat was used at each time point for each strain 
of interest.
cDNA was also prepared from a standard RNA sample 
made from retinal RNA pooled from several room air– and 
cyclic hyperoxia–exposed albino F344 and SD rats and 
pigmented DA rats from various developmental stages, 
ranging from P2 to P14. Each sample was represented equally 
in terms of RNA yield. The standard pool was prepared to 
allow for normalizing RT-qPCR data for gene and small 
ncRNA expression in the context of OIR. The standard pool 
was prepared to allow all strains, treatment groups, and 
developmental stages to be covered, as well as providing 
sufficient RNA for normalization across multiple experi-
ments to be performed.
RT-qPCR analysis of 5S RNA expression: RT-qPCR was 
performed with reference to the Minimum Information for 
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Publication of Quantitative Real-Time PCR Experiments 
guidelines [32]. Each 10 μl reaction mixture contained 5 μl 
of Power SYBR Green PCR Master Mix (Applied Biosys-
tems, Foster City, CA), 1 μl each forward and reverse primers 
(0.5 μM final concentration), and 3 μl cDNA sample diluted 
1:5 with Ultrapure water (Fisher Biotech, WA, Australia). 
Reactions were run on a StepOne Plus real-time PCR System 
(Applied Biosystems). The cycling conditions were initial 
denaturation (95 °C, 15 min) followed by 40 cycles of dena-
turation (95 °C, 15 s), annealing, and extension (60 °C, 30 s).
Primers specific for rat 5S rRNA were published previ-
ously [33]. The sequences for each primer were as follows: 
The forward primer was 5′-TCT CGT CTG ATC TCG GAA 
GC-3′, and the reverse primer was 5′-AGC CTA CAG CAC 
CCG GTA TT-3′. Primers were synthesized by Geneworks 
Ltd (Thebarton, South Australia, Australia).
Assays for RT-qPCR analysis of miRNA expression: TaqMan 
miRNA assays (Applied Biosystems) were used to deter-
mine miRNA expression levels in the retinal, liver, brain, 
lung, and lens samples. Eight commercially available small 
ncRNA controls, referred to as “endogenous controls” by 
Applied Biosystems, were chosen for analysis. In addition to 
these endogenous controls, four miRNAs considered stably 
expressed with strain and treatment were included. They were 
manually identified from data derived from Exiqon miRNA 
arrays (Exiqon A/S, Vedbaek, Denmark) performed at the 
Adelaide Microarray Centre (Adelaide, Australia) using 
Exiqon miRNA version 8.1 and version 11 all species array 
libraries. Briefly, microarray libraries were printed onto 
slides. Retinal-derived total RNA were labelled, hybrid-
ized and scanned according to the manufacturer’s protocol. 
Preliminary Exiqon microarray data analyses were performed 
at the Adelaide Microarray Centre using the software 
package LIMMA R (WEHI, Melbourne, VIC, Australia) to 
identify differentially expressed miRNAs. The full micro-
array processing protocol and statistical analyses has been 
described elsewhere [34]. The arrays were used to identify 
miRNAs that were differentially expressed as a result of rat 
strain and/or changes to oxygen levels. Thirteen ncRNAs 
(including 5S rRNA) were tested before RT-qPCR quanti-
fication of miRNA expression. The corresponding Applied 
Biosystems TaqMan miRNA assay reference numbers are 
shown in Table 1. Primer amplification efficiencies for each 
small ncRNA were determined using the standard RNA 
sample.
RT-qPCR analysis of miRNA expression: cDNA synthesis and 
qPCR reactions were performed using a StepOne Plus real-
time PCR System (Applied Biosystems). Conversion of total 
RNA to single-stranded cDNA was performed in accordance 
with the manufacturer’s instructions for the TaqMan miRNA 
assays with slight modifications as detailed. Briefly, total 
RNA samples were diluted to a concentration of 4, 20, or 
40 ng/μl depending on the optimized template concentration 
determined for each miRNA of interest. A total of 5–40 ng of 
RNA was used in each reverse transcription reaction.
The reverse transcription reaction was modified to 
7.5 μl rather than 15 μl reactions and the volumes adjusted 
accordingly. A bulk reverse transcription master mix was 
prepared containing 100 mM deoxynucleotide triphosphates 
(with deoxythymidine triphosphate, 0.075 μl/reaction), Multi-
scribe™ Reverse Transcriptase 50 U/μl (0.5 μl/reaction), 10 
x Reverse Transcriptase Buffer (0.75 μl/reaction), RNase 
Inhibitor 20 U/μl (0.095 μl/reaction) and nuclease-free water 
(2.08 μl/reactions). The reverse transcription master mix (3.5 
μl/reaction) was then aliquoted into a 96 well reaction plate 
with 0.1 ml well volume (Applied Biosystems) and miRNA-
specific RT primer (1.5 μl/reaction) added. The diluted total 
RNA (2.5 μl/reaction) was then added to bring the final 
volume to 7.5 μl.
The reactions were incubated for 30 min at 16 °C and 
then followed by 30 min of incubation at 42 °C. The reaction 
was then terminated at 85 °C for 5 min before being held 
at 4 °C until required for qPCR that was performed on the 
same day.
A PCR master mix was prepared for each reference small 
ncRNA gene. Each 10.3 μl reaction contained 0.5 μl 20X 
TaqMan miRNA assay mix, 5 μl TaqMan 2X Fast Universal 
PCR Master Mix No Amperase UNG, 3.8 μl of nuclease-free 
water, and 1 μl of the reverse transcription product. Each 
reaction was performed in triplicate. Nuclease-free water was 
used in place of the reverse transcription template as a nega-
tive control for non-specific amplification. PCR reactions 
were placed in the StepOne Plus cycler, and the AmpliTaq 
DNA polymerase was activated at 95 °C for 20 s, followed by 
40 cycles of denaturing at 95 °C for 1 s, and then annealing 
and extension at 60 °C for 20 s. Again, a single representative 
room air– or cyclic hyperoxia–exposed rat was used at each 
time point for each strain of interest.
Determination of PCR primer amplification efficiencies: 
PCR primer amplification efficiencies were determined for 
the 5S rRNA primer pair using ten threefold serial dilutions 
of the standard cDNA sample derived from rat retinal tissue 
to generate a standard curve. Dilutions were made over five 
orders of magnitude; however, reliable data were generated 
only to four logs. For miRNA primer pairs, nine fourfold 
serial dilutions of the standard RNA sample from rat retinal 
tissue were used to generate the standard curve. Depending 
on the miRNA primer pair, reliable data were generated to a 
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minimum of two logs and a maximum of four logs. Although 
data from the standard curve would ideally extend to five 
orders of magnitude to determine PCR amplification effi-
ciency accurately, the abundance of each mRNA or miRNA 
in the sample of interest was a limiting factor.
Standard curves for five small ncRNA primer pairs were 
also performed on total RNA derived from rat liver samples 
to determine if poor amplification efficiencies were due to 
the tissue-specificity of the ncRNA in question. In these 
instances, six twofold serial dilutions of the standard RNA 
sample were used to generate the standard curve over two 
orders of magnitude. A smaller dilution factor was used for 
the miRNA primer pairs to ensure that the majority of the 
threshold cycle values fell within the range of 20–30.
For all primer pairs, the mean threshold cycle value for 
each dilution was plotted against the log cDNA concentra-
tion, and the gradient of the regression line of the standard 
curve was used to calculate the PCR amplification efficiency. 
Amplification efficiencies were used in quantifying gene and 
miRNA expression in the context of OIR [35,36].
Statistics: All statistical analyses were performed using 
the software package PASW Statistics version 18.0 (SPSS 
Inc., Chicago, IL). Independent-samples Student t tests or 
Mann–Whitney U tests were performed to compare stability 
of the small ncRNAs between strains or cyclic hyperoxia 
exposure, and the significance level (alpha) was set at 0.05. 
Statistical analysis for small ncRNA expression in response to 
development was performed using one-way between-groups 
analysis of variance (ANOVA), with the significance (alpha) 
level adjusted for multiple comparisons (Tukey’s honestly 
significant difference test) to p<0.0125. Where appropriate, a 
Kruskal–Wallis test with the significance (alpha) level set at 
0.05 was used instead.
RESULTS
Eight small ncRNA endogenous controls available from 
Applied Biosystems, four miRNAs manually identified from 
in-house Exiqon microarray data to be stably expressed 
with strain and exposure to cyclic hyperoxia, and the small 
ncRNA 5S rRNA were tested using RT-qPCR. Primer PCR 
amplification efficiencies from total RNA derived from rat 
retinal samples were determined using the standard RNA 
sample (Table 1). The linearity of the primer pairs exhibited 
R2 values ranging from 0.98 to 1.00 over a minimum of two 
orders of magnitude. Amplification efficiencies were unable 
to be determined for some assays including 4.5S RNA (H) 
“Variant 5,” snoRNA202, snoRNA, and Y1. These small 
ncRNAs may not be highly expressed in the neonatal rat 
retina; therefore, expression was examined in the rat liver 
(Table 2) and the mouse lens and liver (data not shown). In 
Table 1. Small ncRna SuiTabiliTy aS RefeRence geneS foR noRmalizaTion of miRna expReSSion in RaT ReTinal SampleS.
Small ncRNA Species reactivity Assay ID
Amplification effi-
ciency in rat retina
Order of 
magnitude R
2 value Mean Ct
4.5S RNA(H)* “Variant 1” Rat 001716 49.3% 2.4 1.00 24.1
4.5S RNA(H)* “Variant 5” Rat 001717 ND – low abundance ND ND ND
snoRNA202* Mouse 001232 ND – low abundance ND ND ND
snoRNA* Rat 001718 ND – low abundance ND ND ND
U6 snRNA* Human, mouse and rat 001973 56.2% 4.2 1.00 20.9
RNU6B* Human 001093 ND – low abundance ND ND ND
Y1* Rat 001727 ND – low abundance ND ND ND
U87* Rat 001712 62.0% 2.4 0.98 23.8
5S rRNA Rat N/A 92.5% 4.0 0.98 23.0
hsa-miR-16 + Human, mouse and rat 000391 77.5% 4.2 0.98 24.2
mmu-miR-379+ Human, mouse and rat 001138 ND – low abundance ND ND ND
hsa-miR-191+ Human, mouse and rat 002299 ND – low abundance ND ND ND
hsa-let-7d+ Human, mouse and rat 002283 ND – low abundance ND ND ND
Thirteen small ncRNAs were tested for miRNA normalization. Applied Biosystems assay ID numbers are provided for all small ncRNAs 
other than 5S rRNA, which was not available as an Applied Biosystems TaqMan assay. PCR primer amplification efficiencies were deter-
mined using serial dilutions of the standard RNA pool to a minimum of 2 orders of magnitude to generate a standard curve. The order of 
magnitude of the standard curve dilution series, the R2 value for each standard curve and the mean Ct across all test samples, including the 
standard pool is shown. N/A=not available; ND=not able to be determined; *=small ncRNA assays referred to as endogenous controls by 
Applied Biosystems; +=miRNA identified from in-house Exiqon microarrays as being stably expressed with strain and oxygen exposure.
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rat liver, 4.5S RNA (H) “Variant 1” was expressed, however 
4.5S RNA (H) “Variant 5” was not highly expressed and 
the PCR amplification efficiency could not be determined. 
Interestingly, the same expression pattern was observed in 
the rat brain and lung (data not shown), suggesting that the 
4.5S RNA (H) variants are not expressed to the same extent 
in different rat tissues. Y1 expression levels were low in the 
rat retina and liver. No cross-reactivity of the mouse-specific 
snoRNA202 assay was observed in the rat retina or liver; 
however, expression was confirmed in the mouse lens and 
liver (data not shown).
U6 snRNA, miR-16, U87, 4.5S RNA (H) “Variant 1”, and 
5S rRNA were chosen for further analysis, as the expression 
levels of these small ncRNAs were adequate for determining 
primer PCR amplification efficiencies. The small ncRNAs’ 
stability with strain, treatment, and developmental stage was 
tested using representative samples from individual rats from 
P5, P6, P9, and P14, relative to the standard pool.
Effect of strain: The expression of each small ncRNA was 
separated based on the rat strain. The small ncRNA reference 
gene commonly used for normalizing miRNA expression in 
OIR, 5S rRNA, was the least stable of the five tested (Table 
3). Analysis of the average expression level of each small 
ncRNA, relative to the standard pool, confirmed that little 
variation was present in U6 snRNA, miR-16, U87, and 4.5S 
RNA (H) “Variant 1” expression. However, the changes in 
expression among strains were not statistically significant for 
any gene.
Effect of exposure to cyclic hyperoxia: Expression of each 
small ncRNA separated based on room air or cyclic hyperoxia 
exposure showed 5S rRNA was the least stable reference tran-
script; however, this was not statistically significant (Table 
4). Expression of U87, miR-16, and 4.5S RNA (H) “Variant 
1” was somewhat variable with exposure to cyclic hyperoxia, 
although not to the same extent as for 5S rRNA. U6 snRNA 
showed the smallest change in average expression with fluc-
tuations in oxygen levels. Overall, no changes in response to 
cyclic hyperoxia exposure were statistically significant.
Effect of developmental stage: Levels of U6 snRNA and 
miR-16 showed slight increases with increasing develop-
mental age; however, these differences were not statistically 
significant (Figure 1). U87 levels were stable between P5, 
P6, and P9; however, by P14, expression had increased to 
a statistically significant level after correction for multiple 
comparisons. Levels of 4.5S RNA (H) “Variant 1” varied with 
developmental stages. A statistically significant decrease in 
expression levels occurred between P6 and P9, and a statisti-
cally significant increase in expression levels was observed 
Table 2. pcR pRimeR amplificaTion efficiencieS of Small ncRna endogenouS conTRolS in RaT liveR.
Small ncRNA Amplification efficiency in rat liver R2 value Ct at 1/2 dilution
4.5S RNA(H) “Variant 1” 44.6% 0.99 25.4
4.5S RNA(H) “Variant 5” ND – low abundance ND 33.1
snoRNA202 ND – low abundance ND 33.0
snoRNA 50.4% 1.00 26.9
Y1 ND – low abundance ND 34.5
Five small ncRNA endogenous controls were tested to determine the PCR primer amplification efficiencies using total RNA derived from 
rat liver samples. Six serial twofold dilutions of the total RNA were used to generate the standard curves for 4.5S RNA (H) “Variant 1” 
and snoRNA. Cts were unable to be generated for all six twofold serial dilutions for the remaining small ncRNAs; therefore amplification 
efficiencies for these assays could not be determined. The R2 value for each standard curve is shown, as is the mean Ct at a 1/2 dilution. 
ND=not able to be determined.
Table 3. expReSSion of five Small ncRnaS and miRnaS RelaTive To a STandaRd pool TeSTed foR STabiliTy beTween RaT STRainS.
Assay Expression relative to the standard pool in F344 rats
Expression relative to the 
standard pool in SD rats
Difference in mean expression 
between F344 and SD rats p value
U6 snRNA 0.48 (±0.13) 0.45 (±0.13) 0.03 0.70
miR-16 0.66 (±0.33) 0.56 (±0.23) 0.10 0.50
U87 0.93 (±0.19) 0.90 (±0.21) 0.03 0.56
4.5S RNA(H) 
“Variant 1”
0.96 (±0.08) 0.90 (±0.21) 0.06 0.47
5S rRNA 0.63 (±1.13) 0.47 (±0.39) 0.16 0.53
Average expression relative to the standard pool and the standard deviation for each strain is shown. F344 n=8, SD n=8.
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between P9 and P14. Levels of 5S rRNA, relative to the stan-
dard pool, increased with developmental age up to P9 and 
then decreased at P14.
DISCUSSION
The current convention for quantifying miRNA expression 
is to use a single small ncRNA reference gene for normal-
izing RT-qPCR data [37]. The choice of small ncRNA 
reference gene is important to avoid introducing bias or 
misleading conclusions. Gee et al. found that the expression 
of small ncRNA reference genes typically used for normal-
izing miRNA expression levels in cancer were themselves 
highly variable [10]. When these reference genes were 
used to normalize expression levels of miRNAs of interest 
from tumor samples, the potential prognostic value of these 
miRNAs was lost, as their normalized expression levels 
did not accurately reflect the associations between miRNA 
expression and tumor pathology or disease outcome [10]. 
These reference transcripts were later found to be derived 
from the introns of genes that themselves are dysregulated 
in cancer [10].
An ideal reference gene for use with rodent models of 
OIR is stable with strain, exposure to cyclic hyperoxia, and 
developmental stage. Previous studies of miRNA expression 
in mouse oxygen-induced retinopathy have used 5S rRNA 
as the reference RNA for normalizing miRNA expression 
[24-26], although the suitability of this reference gene for 
the purpose was hitherto unknown. Here, we showed that 5S 
rRNA levels varied with rat strain, changes in oxygen levels, 
and developmental stage, but this variability was not statisti-
cally significant. Some of the variation observed in 5S rRNA 
expression may be due to the different chemistries used to 
Table 4. expReSSion of five Small ncRnaS and miRnaS RelaTive To a STan-
daRd pool TeSTed foR STabiliTy wiTh expoSuRe To cyclic hypeRoxia.
Assay
Expression relative to the 
standard pool in room 
air-exposed rats
Expression relative to the 
standard pool in cyclic 
hyperoxia-exposed rats
Difference in expression between 
room air- and cyclic hyperoxia-
exposed rats
p value
U6 snRNA 0.49 (±0.16) 0.47 (±0.11) 0.03 0.70
miR-16 0.67 (±0.26) 0.55 (±0.31) 0.12 0.41
U87 0.85 (±0.15) 0.98 (±0.22) 0.13 0.08
4.5S RNA(H) 
“Variant 1”
0.96 (±0.08) 0.90 (±0.21) 0.06 0.47
5S rRNA 0.28 (±0.25) 0.82 (±1.10) 0.54 0.20
Mean expression relative to the standard pool and the standard deviation are shown for each treatment. Room air-exposed rats n=8, cyclic 
hyperoxia-exposed rats n=8.
Figure 1. Average expression of 
five small ncRNAs and miRNAs 
compared at P5, P6, P9, and P14. 
Mean expression relative to the 
standard pool for each develop-
mental stage. n=4 at each time 
point. Error bars represent  ± stan-
dard deviation. Statistical analysis 
was performed using one-way 
ANOVA, with the significance 
level (alpha) adjusted for multiple 
comparisons (Tukey’s HSD test) 
at p<0.0125. For 5S rRNA, a 
Kruskal–Wallis test was used and 
the significance (alpha) level set at 
0.05. * p<0.0125.
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assay 5S rRNA expression levels (SYBR Green) compared 
with miRNA expression levels (TaqMan). However, expres-
sion of the 5S rRNA transcript was compared across samples 
within an assay method, rather than between methods, so that 
the variability is likely due to strain, oxygen exposure, or 
developmental stage. Previous studies of miRNA expression 
in mouse oxygen-induced retinopathy also used SYBR Green 
chemistry and TaqMan assays for analyzing 5S rRNA and 
miRNA expression levels, respectively [24,25]. Given that 5S 
rRNA expression levels varied between samples, we conclude 
that in at least this rat model of OIR, 5S rRNA is not a suitable 
reference RNA for normalizing miRNA expression levels.
U6 snRNA levels were stable with fluctuations in oxygen, 
strain, and developmental stage compared to the remaining 
four reference genes. However, the PCR amplification effi-
ciency was only 56% for this particular assay. In comparison, 
miR-16 showed less stable average expression with changes 
in oxygen levels and between rat strains compared with U6 
snRNA. Some variation in expression was observed with 
developmental stage, but less than that seen with 5S rRNA. 
The PCR amplification efficiency for the miR-16 TaqMan 
assay was better than for U6 snRNA, at 78%. The remaining 
two reference RNAs, 4.5S RNA (H) “Variant 1” and U87, 
showed poor PCR amplification efficiencies in neonatal rat 
retinas with efficiencies of 49% and 62%, respectively, and 
were variable with strain, exposure to cyclic hyperoxia, and 
developmental stage. Statistically significant changes in small 
ncRNA expression were observed in response to develop-
mental stage for 4.5S RNA (H) “Variant 1” and U87.
5S rRNA has typically been used for normalizing 
miRNA expression levels in mouse models of oxygen-
induced retinopathy, although the stability of this reference 
gene with changes in oxygen levels has not previously been 
examined. We have established that data derived from the use 
of 5S rRNA for normalization is statistically valid. However, 
the lower degree of variability observed in expression levels 
of U6 snRNA and miR-16 suggest they may be more appro-
priate for use in normalizing miRNA expression levels. Taken 
together, the data suggest that from the limited number of rat-
reactive small ncRNA control TaqMan assays available U6 
snRNA and miR-16 are most suitable for normalizing miRNA 
expression in rat models of OIR, as these reference genes are 
relatively stable with strain, exposure to cyclic hyperoxia, and 
developmental stage.
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